Premia China STAR50 ETF(03151.HK) rose 4.88% to close at HKD 10.960
Newtimespace News, as of the close on April 30, Premia China STAR50 ETF(03151.HK) closed at HKD 10.960, up 4.88%. The ETF opened at HKD 10.650, with a high of HKD 11.000 and a low of HKD 10.650. The latest trading volume was 422,600 units, with a total turnover of HKD 4.5967 million. The asset size is approximately HKD 737 million.
Premia China STAR50 ETF(03151.HK) tracks the SSE STAR Market 50 Index, which is jointly compiled by the Shanghai Stock Exchange and China Securities Index Co., Ltd. The index selects the 50 securities with the largest market capitalization and best liquidity on the STAR Market, aiming to reflect the overall performance of the most market-representative batch of companies listed on the STAR Market. Its constituents are mainly concentrated in high-tech industries and strategic emerging industries such as next-generation information technology, biomedicine, high-end equipment, new materials, and new energy. It serves as a gathering place for China's "hard tech" enterprises, characterized by high growth potential and relatively high volatility.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million